Q2 Earnings Forecast for Acadia Healthcare Issued By KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at KeyCorp cut their Q2 2025 earnings per share estimates for Acadia Healthcare in a report released on Monday, January 6th. KeyCorp analyst M. Gillmor now forecasts that the company will post earnings of $0.85 per share for the quarter, down from their prior estimate of $1.00. KeyCorp currently has a “Overweight” rating and a $70.00 target price on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.92 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the previous year, the company posted $0.91 EPS. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year.

Other research analysts have also issued reports about the company. TD Cowen decreased their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, Barclays lowered their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $45.13 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The firm has a market cap of $4.19 billion, a PE ratio of 14.80, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company’s 50 day moving average is $40.57 and its two-hundred day moving average is $58.37.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares during the period. Commonwealth Equity Services LLC boosted its stake in Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the period. Atria Investments Inc increased its stake in Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares during the period. KBC Group NV raised its holdings in shares of Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares during the last quarter. Finally, Tidal Investments LLC boosted its stake in shares of Acadia Healthcare by 7.9% during the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.